BACKGROUND: To clarify the relationship between the probability of @entity263 scaled using a 5-point Likert system and the biological characteristics of corresponding @entity5 foci. METHODS: The present study involved 44 @entity1 undergoing 3.0-Tesla multiparametric MRI before laparoscopic radical prostatectomy. Tracing based on pathological and MRI findings was performed. The relationship between the probability of @entity5 scaled using the 5-point Likert system and the biological characteristics of corresponding @entity5 foci was evaluated. RESULTS: A total of 102 @entity5 foci were identified histologically from the 44 specimens. Of the 102 @entity5 , 55 were assigned a score based on MRI findings (score 1: n   =   3; score 2: n   =   3; score 3: n   =   16; score 4: n   =   11 score 5: n   =   22), while 47 were not pointed out on MRI. The tracing study revealed that the proportion of >0.5 cm(3) @entity5 increased according to the upgrade of Likert scores (score 1 or 2: 33 %; score 3: 68.8 %; score 4 or 5: 90.9 %,    (2) test, p   <   0.0001). The proportion with a Gleason score >7 also increased from scale 2 to scale 5 (scale 2: 0 %; scale 3: 56.3 %; scale 4: 72.7 %; 5: 90.9 %,    (2) test, p   =   0.0001). On using score 3 or higher as the threshold of @entity5 detection on MRI, the detection rate markedly improved if the @entity5 volume exceeded 0.5 cm(3) (<0.2 cm(3): 10.3 %; 0.2-0.5 cm(3): 25 %; 0.5-1.0 cm(3): 66.7 %; 1.0   <   cm(3): 92.1 %). CONCLUSIONS: Each Likert scale favobably reflected the corresponding @entity5 's volume and Gleason score. Our observations show that "score 3 or higher" could be a useful threshold to predict clinically significant @entity189 when considering treatment options.

Five-point Likert scaling on MRI predicts clinically significant XXXX .

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'cancer', 'tumors'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity263 :: ('MESH:D011471', 'Disease') :: ['prostate cancer'] @entity189 :: ('MESH:D002277', 'Disease') :: ['carcinoma']
@entity263 :: (MESH:D011471,Disease) :: ['prostate carcinoma']
